Director/PDMR Shareholding
Bioventix PLC announced that on 4 November 2025, Chief Executive Officer Peter Harrison and his wife, Abigail Harrison, each purchased 875 ordinary shares at 2,220 pence per share on the London Stock Exchange's AIM Market. These transactions collectively represent a purchase of 1,750 shares. Following this director dealing, Peter Harrison, along with his closely associated persons, now holds a beneficial interest in 304,042 Ordinary Shares, equating to approximately 5.8 per cent of the company's issued share capital. This increased insider ownership typically signals management's confidence in the company's future prospects, which could positively influence investor sentiment.
Select text to share a quote on X · sign in to keep highlights & notes in your BVXP notes
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company has been notified that earlier today Peter Harrison, Chief Executive Officer, and his wife Abigail Harrison have purchased ordinary shares of 5 pence each in the Company ("Ordinary Shares") at the quantities and prices set out in the table below.
| Director/PDMR | Position | No of shares purchased | Purchase Price |
|---|---|---|---|
| Peter Harrison | Chief Executive Officer | 875 | 2,220 pence |
| Abigail Harrison | PCA of Peter Harrison | 875 | 2,220 pence |
Following the Purchase, Peter Harrison, together with his persons closely associated, has a beneficial interest in 304,042 Ordinary Shares, representing approximately 5.8 per cent. of the issued share capital of the Company.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Peter Harrison |
| 2. | Reason for the Notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Bioventix Plc |
| b) | LEI | 213800225MHX7LZQY108 |
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each |
| Identification code | GB00B4QVDF07 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | 875 Ordinary Shares 2,220 pence |
| d) | Aggregated information: · Aggregated volume · Price | Single transaction as in 4c) above |
| e) | Date of the transaction | 4 November 2025 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Abigail Harrison |
| 2. | Reason for the Notification | |
| a) | Position/status | Wife of and PCA with Peter Harrison, Chief Executive Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Bioventix Plc |
| b) | LEI | 213800225MHX7LZQY108 |
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each |
| Identification code | GB00B4QVDF07 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | 875 Ordinary Shares 2,220 pence |
| d) | Aggregated information: · Aggregated volume · Price | Single transaction as in 4c) above |
| e) | Date of the transaction | 4 November 2025 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.